Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what funding is allocated for research into treatments for Motor Neurone Disease.

Government responsibility for delivering motor neurone disease (MND) research is shared between the Department of Health and Social Care, with research delivered by the National Institute for Health and Care Research (NIHR), and the Department for Science, Innovation and Technology, with research delivered via UK Research and Innovation, primarily by the Medical Research Council.

It is not the usual process of the NIHR to allocate funds for research into specific conditions. The NIHR welcomes funding applications for research into any aspect of human health and care, including MND. Our approach to funding research is through open and fair competition and peer review to ensure that the highest-quality proposals, most likely to deliver real impact for patients, are funded without imposing financial targets or limits.

The Government is investing in MND research across a range of areas, including possible treatments. For example, the MND Translational Accelerator, supported by £6 million of Government funding, has twelve projects all aimed at speeding up the development of treatments for MND.

The NIHR has also invested £8 million into EXPERTS-ALS, a pre-clinical study which is designed to accelerate the identification and testing of the most promising treatment candidates for treating amyotrophic lateral sclerosis, the most common form of MND. This will connect to the later phase platform trial, MND SMART.

Welcoming applications on MND to all NIHR programmes enables maximum flexibility both in terms of amount of research funding a particular area can be awarded, and the type of research which can be funded.